Medicinal Chemistry & Computer Aided Drug Designing

Biography

Ioannis Grigoriadis has completed his PharmacistD at the age of 24 years from Aristotle University of Thessaloniki and doctoral studies from University of Ioannina Medical School. He is the scientific director of Biogenea Pharmaceuticals Ltd, a premier biotechnology personalized cancer vaccination service organization. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute.

Abstract

Abstract : Development of a novel class of hyper-multi-targeted computer-aided CREKA/YIGSR-peptide mimotopic dual Inhibitor against tumor growth, metastasis related glioblastoma conserved motif-like peptide domains VDAC1-peptide mimetic tubulin targeted HA14-1-based multivalent chemical inhibitorory promising anticancer activities as novel in silico high binding free energy affinity value pro-apoptotic annotated agent for B-cell chronic lymphocytic leukemia.